Tata India Pharma & Healthcare Fund vs Quant Healthcare Fund Regular compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Quant Healthcare Fund Regular - Growth
Chart Comparison
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1208 Cr | ₹437 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹1000 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 28 Dec 2015 | 17 Jun 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare TRI |
| Turn Over | 26.49% | % |
| Expense Ratio | 2.14 | 2.38 |
| Manager | Meeta Shetty | Sanjeev Sharma |
| ISIN Code | INF277K016A9 | INF966L01CG3 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Month | 4.66% | -2.83% |
| 6 Month | 16.53% | 3.53% |
| 1 Year | 41.34% | 31.17% |
| 3 Year | 22.4% | - |
| 5 Year | 27.33% | - |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 31.82% | 12.42% |
| 3 Year | 32.32% | - |
| 5 Year | 25.8% | - |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Year | 6.67% | 59.34% |
| 3 Year | 17.46% | - |
| 5 Year | 14.22% | - |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Standard Deviation | 14.23% | - |
| Sharp | 0.74% | - |
| Beta | 0.9% | - |
| Alpha | 2.85% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Name | Meeta Shetty | Sanjeev Sharma |
| Total AUM | ₹17847 Cr | ₹39731 Cr |
| Fund Manage | 5 | 22 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 5.39 | 5.19 |
| Small Cap | 23.46 | 60.53 |
| Large Cap | 40.33 | 15.52 |
| Mid Cap | 30.82 | 18.76 |
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 5.39 | 5.19 |
| Pharmaceuticals & Biotechnology | 76.28 | 64.82 |
| Healthcare Services | 14.31 | 9.02 |
| Fertilizers & Agrochemicals | 0.83 | - |
| Chemicals & Petrochemicals | 0.39 | - |
| Insurance | 2.14 | - |
| Retailing | 0.66 | - |
| Petroleum Products | - | 7.46 |
| Telecom - Services | - | 7.82 |
| Food Products | - | 5.69 |
Top Comparisons
PGIM India Global Equity Opportunities Fund - Growth
3Y Returns5.54%
Axis Global Equity Alpha Fund of Fund - Regular Plan - Growth Option
3Y Returns9.14%
Mahindra Manulife Multi Cap Fund - Regular Plan - Growth
3Y Returns19.48%
HSBC Multi Cap Fund - Regular - Growth
3Y Returns0%
Franklin India Equity Hybrid Fund - Growth Plan
3Y Returns15.53%
Kotak Equity Hybrid - Growth
3Y Returns15.89%
BANDHAN Bond Fund - Medium Term - Regular Plan - Growth
3Y Returns4.92%
Aditya Birla Sun Life Medium Term Plan - Growth - Regular Plan
3Y Returns13.65%